Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Blood|October 2, 2024
How I treat older patients with relapsed/refractory diffuse large B-cell lymphomaDanielle S Wallace, Kah Poh Loh, Carla Casulo
International Journal of Surgical Pathology|July 4, 2025
Clinicopathologic Findings in T-Cell Large Granular Lymphocytic Leukemia-Associated Gamma Heavy Chain DiseaseGiby V George, Danielle S Wallace, Chauncey R Syposs
Ejhaem|June 19, 2024
Clonally unrelated primary large B-cell lymphomas separated by over a decade involving the central nervous system and testicle: Possible predisposition to lymphomas of immune-privileged sites?Giby V George, Diana G Aldowitz, Audrey N Jajosky, et al.
Blood Advances|January 23, 2023
Acalabrutinib and high-frequency low-dose subcutaneous rituximab for initial therapy of chronic lymphocytic leukemiaDanielle S Wallace, Clive S Zent, Andrea M Baran, et al.
Journal of Adolescent and Young Adult Oncology|September 3, 2025
Real World Data Identifies Care Needs in Adolescent and Young Adult Patients with Lymphoma: A Matched Cohort StudyJohn Mariano, Myla Strawderman, Eric Snyder, et al.
Journal of Geriatric Oncology|March 7, 2026
Brentuximab vedotin and dose attenuated chemoimmunotherapy for patients 75 years and older with diffuse large B-cell lymphoma with analysis of outcomes by frailtyPatrick M Reagan, Allison Magnuson, Craig A Portell, et al.
Leukemia & Lymphoma|March 17, 2020
Additional B-cell malignancies in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL)Philip J Meacham, AnnaLynn M Williams, Myla Strawderman, et al.
Leukemia Research|April 1, 2023
Rituximab induced cytokine release with high serum IP-10 (CXCL10) concentrations is associated with infusion reactionsJeremiah E Moore, Paige C Bloom, Charles C Chu, et al.
Blood Advances|October 23, 2023
Response-adapted, time-limited venetoclax, umbralisib, and ublituximab for relapsed/refractory chronic lymphocytic leukemiaBrian T Hill, Shuo Ma, Clive S Zent, et al.
Blood Advances|February 18, 2026
Patterns of Care and Clinical Outcomes in Systemic Peripheral T-cell Lymphoma: The LEO-MER Prospective Cohort StudyJia Ruan, Zhengming Chen, Melissa C Larson, et al.
Pageof 2